Impactive Capital LP 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-10-28 4:30 pm Sale | 2022-10-27 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 1,910,919 4.400% | -495,639 (-20.60%) | Filing |
| 2022-10-18 4:45 pm Sale | 2022-10-14 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 2,406,558 5.500% | -494,628 (-17.05%) | Filing |
| 2022-09-19 4:51 pm Sale | 2022-09-15 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 2,901,186 6.600% | -639,355 (-18.06%) | Filing |
| 2022-09-07 4:36 pm Sale | 2022-09-02 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 3,540,541 8.100% | -781,428 (-18.08%) | Filing |
| 2022-02-04 5:09 pm Purchase | 2022-01-25 | 13D | Meridian Bioscience, Inc. VIVO | Impactive Capital LP | 4,321,969 9.900% | 4,321,969 (New Position) | Filing |